How High Novo Nordisk Could and Should Go for Ablynx Post author:Sam Post published:January 23, 2018 Post category:BioPharma Novo has tried to apply pressure, but the ABLX board and principal shareholder have not been moved. Source: BioSpace You Might Also Like AstraZeneca PLC Offloads Heart Drugs to Recordati in $300 Million Deal to Pump Up R&D May 21, 2017 Perrigo Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen February 27, 2017 Google Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily Campus to Sweeten Deal July 24, 2017
Perrigo Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen February 27, 2017
Google Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily Campus to Sweeten Deal July 24, 2017